IONS is Ionis Pharmaceuticals, Inc. Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $58.09. Market cap: $9.65B. Capital Quality Rank: 83/100 — Elite compounder.
Stock snapshot
| Price | $58.09 |
| Market cap | $9.65B |
| Sector | Healthcare |
| Exchange | XNAS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 83 / 100 · Elite compounder |
| ROIC (TTM) | -21.0% |
| Revenue CAGR (3y) | 17.1% |
| Shareholder buyback yield | -6.56% |
| Altman Z-score zone | Grey |
About IONS
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis marked its first two independent launches in 2025 for Tryngolza (for FCS) and Dawnzera (for HAE).
Related non-dividend companies
Other non-dividend stocks investors research alongside IONS. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is IONS's current stock price?
IONS (Ionis Pharmaceuticals, Inc. Common Stock) is currently trading at $58.09.
Does IONS pay a dividend?
IONS (Ionis Pharmaceuticals, Inc. Common Stock) does not currently pay a regular dividend.
What is IONS's Capital Quality Rank?
IONS has a Capital Quality Rank of 83/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track IONS in DiviDrip
Add IONS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search IONS and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.